These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3097716)

  • 1. Behavioral and physiological effects associated with changes in muscarinic receptors following administration of an irreversible cholinergic agonist (BM 123).
    Russell RW; Smith CA; Booth RA; Jenden DJ; Waite JJ
    Psychopharmacology (Berl); 1986; 90(3):308-15. PubMed ID: 3097716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and physiological effects of an aziridinium analog of oxotremorine (BM130).
    Russell RW; Crocker AD; Booth RA; Jenden DJ
    Psychopharmacology (Berl); 1986; 88(1):24-32. PubMed ID: 3080775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with an irreversible muscarinic agonist affects responses to apomorphine.
    Crocker AD; Russell RW
    Pharmacol Biochem Behav; 1990 Mar; 35(3):511-6. PubMed ID: 2339142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alkylating derivative of oxotremorine interacts irreversibly with the muscarinic receptor.
    Ehlert FJ; Jenden DJ; Ringdahl B
    Life Sci; 1984 Mar; 34(10):985-91. PubMed ID: 6700365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conversion of 2-chloroalkylamine analogues of oxotremorine to aziridinium ions and their interactions with muscarinic receptors in the guinea pig ileum.
    Ringdahl B; Resul B; Ehlert FJ; Jenden DJ; Dahlbom R
    Mol Pharmacol; 1984 Sep; 26(2):170-9. PubMed ID: 6332977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an irreversible muscarinic agonist (BM123) on avoidance and spontaneous alternation performance.
    Overstreet DH; Booth RA; Jenden DJ
    Pharmacol Biochem Behav; 1988 Oct; 31(2):337-43. PubMed ID: 3244711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine.
    Ringdahl B; Katz ED; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1989 Apr; 249(1):210-5. PubMed ID: 2709331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies.
    Engström C; Undén A; Ladinsky H; Consolo S; Bartfai T
    Psychopharmacology (Berl); 1987; 91(2):161-7. PubMed ID: 3107028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.
    Ringdahl B; Jenden DJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):370-5. PubMed ID: 3806401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in behavioral responses to a cholinergic agonist in post-pubertal rats with neonatal ventral hippocampal lesions: relationship to changes in muscarinic receptor levels.
    Laplante F; Nakagawasai O; Srivastava LK; Quirion R
    Neuropsychopharmacology; 2005 Jun; 30(6):1076-87. PubMed ID: 15637638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of irreversible loss of muscarinic receptors on (3H)-acetylcholine release from the hippocampus.
    Sethy VH; Hyslop DK
    Neuropharmacology; 1990 Feb; 29(2):185-8. PubMed ID: 2330074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
    Palacios JM; Bolliger G; Closse A; Enz A; Gmelin G; Malanowski J
    Eur J Pharmacol; 1986 Jun; 125(1):45-62. PubMed ID: 3732391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an alkylating derivative of oxotremorine (BM 123A) on heart rate, muscarinic receptors and adenylate cyclase activity in the rabbit myocardium.
    Ehlert FJ
    J Pharmacol Exp Ther; 1987 Jun; 241(3):804-11. PubMed ID: 3598904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Methyl-2-pyrrolidone analogues of oxotremorine as selective muscarinic agonists.
    Ringdahl B
    J Med Chem; 1988 Mar; 31(3):683-8. PubMed ID: 3346881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel alkoxy-oxazolyl-tetrahydropyridine muscarinic cholinergic receptor antagonists.
    Shannon HE; Bymaster FP; Hendrix JC; Quimby SJ; Mitch CH
    Psychopharmacology (Berl); 1995 Jan; 117(2):208-15. PubMed ID: 7753969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of agonists and selective antagonists with gastric smooth muscle muscarinic receptors.
    Lucchesi PA; Romano FD; Scheid CR; Yamaguchi H; Honeyman TW
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):145-51. PubMed ID: 2498669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance.
    Bushnell PJ; Kelly KL; Ward TR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):15-25. PubMed ID: 7518512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological assessment of a new, potent oxotremorine analogue in mice and rats.
    Resul B; Lewander T; Ringdahl B; Zetterström T; Dahlbom R
    Eur J Pharmacol; 1982 May; 80(2-3):209-15. PubMed ID: 7106176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urea and 2-imidazolidone derivatives of the muscarinic agents oxotremorine and N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
    Nilsson BM; Vargas HM; Hacksell U
    J Med Chem; 1992 Aug; 35(17):3270-9. PubMed ID: 1507212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.